We are live on ! Find out more
CYT

Cyteir Therapeutics, Inc. Common Stock
CYT

Delisted

CYT was delisted on the 15th of March, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of CYT yet.

CYT Hedge Fund Activity: Q2 2024 in Review

0 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Cyteir Therapeutics, Inc. Common Stock (CYT) for Q2 2024, worth a combined $0 — down 100% from $11.2M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of CYT and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BML Capital Management, exiting entirely with an estimated $11M sold.

  • 0 institutional investors held Cyteir Therapeutics, Inc. Common Stock (CYT) as of Q2 2024, down from 4 in Q1 2024.
  • Funds reported $0 of Cyteir Therapeutics, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Cyteir Therapeutics, Inc. Common Stock positions in Q2 2024 and 4 closed out, a net change of -4 holders.
  • The largest Cyteir Therapeutics, Inc. Common Stock seller in Q2 2024 was BML Capital Management, an estimated $11M sold.

Based on aggregated 13F filings for Q2 2024.